GSTP1 A1578G (Ile105Val) polymorphism in benzidine-exposed workers: An association with cytological grading of exfoliated urothelial cells

Pharmacogenetics

Volumn 13, Issue 7, 2003, Pages 409-415

  Ma, Qingwen ^a   Lin, Guofang ^a   Qin, Yiqiu ^b   Lu, Daru ^c   Golka, Klaus ^d   Geller, Frank ^e   Chen, Jigang ^b   Shen, Jianhua ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c FUDAN UNIVERSITY   (China)

^d LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Benzidine; Bladder neoplasms; Cytology; Glutathione S transferase pi; Polymorphism

Indexed keywords

BENZIDINE; GLUTATHIONE TRANSFERASE; ISOLEUCINE; VALINE; BENZIDINE DERIVATIVE; CARCINOGEN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER GRADING; CANCER PATIENT; CODON; COHORT ANALYSIS; CYTOLOGY; ENZYME ACTIVITY; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GSTP1 GENE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; UROTHELIUM; AGED; ALLELE; ASIAN; BLADDER TUMOR; CASE CONTROL STUDY; CHINA; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; GENE FREQUENCY; GENETICS; METABOLISM; MIDDLE AGED; RISK; RISK FACTOR; SEX DIFFERENCE; SMOKING; TIME;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BENZIDINES; CARCINOGENS; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; FEMALE; GENE FREQUENCY; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS; SMOKING; TIME FACTORS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0042868369     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200307000-00006     Document Type: Article

References (36)

1. Ahmad H, Wilson DE, Fritz RR, Singh SV, Medh RD, Nagle GT, et al. Primary and secondary structural analyses of glutathione S-transferase pi from human placenta. Arch Biochem Biophys 1990; 278:398-408.
2. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Indentification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18:641-644.
3. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoformes with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994; 224:893-899.
4. Terrier P, Townsend AJ, Coindre JM, Triche TJ, Cowan KH. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol 1990; 137:845-853.
5. Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, Mannervik B, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998; 19:433-436.
6. Hengstler JG, Arand M, Herrero ME, Oesch F. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 1998; 154:47-85.
7. Jourenkova-Mironova N, Voho A, Bouchardy C, Wikman H, Dayer P, Benhamou S, et al. Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk. Cancer Epidemiol Biomarkers Prev 1999; 8:185-188.
8. Park JY, Schantz SP, Stern JC, Kaur T, Lazarus P. Association between glutathione S-transferase Pi genetic polymorphisms and oral cancer risk. Pharmacogenetics 1999; 9:497-504.
9. Matthias C, Beckmühl U, Jahnke V, Harries LW, Wolf CR, Jones PW, et al. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 1998; 8:1-6.
10. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994; 54:5801-5803.
11. Maugard CM, Charrier J, Pitard A, Campion L, Akande O, Pleasants L, et al. Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier. Int J Cancer 2001; 91:334-339.
12. Helzlsouer KJ, Selmin O, Huang HY, Strickland PT, Hoffman S, Alberg AJ, et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 1998; 90:512-518.
13. Steinhoff C, Franke KH, Golka K, Thier R, Römer HC, Rötzel C, et al. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000; 74:521-526.
14. Autrup JL, Thomassen LH, Olsen JH, Wolf H, Autrup H. Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev 1999; 8:525-532.
15. Wadelius M, Autrup JL, Stubbins MJ, Andersson SO, Johansson JE, Wadelius C, et al. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 1999; 9:333-340.
16. Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, et al. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics 2001; 11:757-764.
17. Millikan R, Pittman G, Tse CK, Savitz DA, Newman B, Bell D. Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2000; 9:567-573.
18. Golka K, Prior V, Blaszkewicz M, Cascorbi I, Schöps W, Kierfeld G, et al. Occupational history aspects and genetic N-acetyltransferase (NAT2) polymorphism in urothelial cancer patients of Leverkusen, Germany. Scand J Work Environ Health 1996; 22:332-338.
19. Lin GF, Ma QW, Chen JG, Shen JH, Xiang CQ, Golka K, et al. Dependence of Papanicolaou gradings of exfoliated urothelial cells upon GSTM1 and GSTT1 polymorphism in benzidine-exposed workers of the Shanghai dye industry. Arch Toxicol 2001; 75:544-548.
20. You XY, Chen JG, Yao YF. A retrospective prospective investigation on bladder cancer in the workers exposed to benzidine in Shanghai dyestuff industry [in Chinese]. Tumor 1983; 3:197-201.
21. Papanicolaou GN. A new procedure for staining vaginal smears. Science 1942; 95:438-439.
22. Papanicolaou GN, Marshall VF. Urine sediment smears: a diagnostic procedure in cancer of the urinary tract. Science 1945; 101:519-520.
23. Mason TJ, Prorok PC, Neeld WE Jr, Vogler WJ. Screening for bladder cancer at the DuPont Chambers Works: initial findings. J Occup Med 1986; 28:1011-1116.
24. Shen JH, Lin GF, Yuan WX, Tan JW, Bolt HM, Thier R. Glutathione transferase T1 and M1 genotype polymorphism in the normal population of Shanghai. Arch Toxicol 1998; 72:456-458.
25. Harris MJ, Coggan M, Langton L, Wilson SR, Board PG. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics 1998; 8:27-31.
26. He DL, He HQ (editors). Oncology of male urogenital system [in Chinese]. Xi'an, Shanxi, China: Science & Technology Press of Shanxi; 1999, p. 173.
27. Institute of Oncology, Chinese Academy of Medical Science. Clinical cytological atlas of tumour [in Chinese]. Beijing, China: People's Press of Hygiene; 1984.
28. Hayes RB, Bi W, Rothman N, Broly F, Caporaso N, Feng P, et al. N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis 1993; 14:675-678.
29. Lower GM Jr, Nilsson T, Nelson CE, Wolf H, Gamsky TE, Bryan GT. N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ Health Perspect 1979; 29:71-79.
30. Cartwright RA, Glashan RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins E, et al. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 1982; 2:842-846.
31. Golka K, Prior V, Blaszkewicz M, Bolt HM. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences. Toxicol Lett 2002; 128:229-241.
32. Sone M. Determination of the N-acetyltransferase phenotype in urothelial cancer patients and healthy controls [in Japanese]. Hinyokika Kiyo 1986; 32:1085-1092.
33. Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, et al. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 1999; 9:165-169.
34. Thief R, Golka K, Brüning T, Ko Y, Bolt HM. Genetic susceptibility to environmental toxicants: the interface between human and experimental studies in the development of new toxicological concepts. Toxicol Lett 2002; 127:321-327.
35. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase MI (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85:1159-1164.
36. Golka K, Reckwitz T, Kempkes M, Cascorbi I, Blaszkewicz M, Reich SE, et al. N-Acetyltransferase 2 (NAT2) and glutathione S-transferase (GSTM1) in bladder cancer patients in a highly industrialized area. Int J Occup Environ Health 1997; 3:105-110.